Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 47Leukemia 14Myelodysplastic Syndromes 12Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Biphenotypic, Acute 9Recurrence 8Leukemia, Lymphocytic, Chronic, B-Cell 8Blast Crisis 7Lymphoma, Mantle-Cell 6Leukemia, Hairy Cell 6Leukemia, Monocytic, Acute 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Waldenstrom Macroglobulinemia 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm, Residual 3Myeloproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3Burkitt Lymphoma 3Sarcoma, Myeloid 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Erythroblastic, Acute 2Graft vs Host Disease 2Thrombocythemia, Essential 1Targeted Therapy 1

Interventions

fludarabine phosphate 41Cyclophosphamide 31Mycophenolic Acid 25Whole-Body Irradiation 23Peripheral Blood Stem Cell Transplantation 21Cyclosporine 17Rituximab 16Tacrolimus 15fludarabine 14Antilymphocyte Serum 14Busulfan 12Filgrastim 10Cyclosporins 10Methotrexate 8Sirolimus 7Therapeutics 6Melphalan 5Granulocyte Colony-Stimulating Factor 5Cytarabine 5Cord Blood Stem Cell Transplantation 5ibrutinib 4Psychiatric Rehabilitation 4Pharmacogenomic Testing 4Lenalidomide 4Carboplatin 4Allopurinol 4alvocidib 3Thiotepa 3Flow Cytometry 3Etoposide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Prolymphocytic × Cladribine × Clear all
NCT00003746 2012-05-15

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Swiss Cancer Institute

Phase 3 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡